Evidence map›Paper›PMID 26388873›Full record

ReviewFrontiers in immunology2015

The Cellular Prion Protein: A Player in Immunological Quiescence.

Maren K Bakkebø, Sophie Mouillet-Richard, Arild Espenes, Wilfred Goldmann, Jörg Tatzelt, Michael A Tranulis

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. A Soluble PrPJournal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Role of cellular prion protein in splenic CD4Annals of clinical and translational neurology · 2021
    Article
  16. Review
  17. Review
  18. Microglia in Prion Diseases: Angels or Demons?International journal of molecular sciences · 2020
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Maren K BakkebøDepartment of Basic Sciences and Aquatic Medicine, Faculty of Veterinary Medicine and Biosciences, Norwegian University of Life Sciences , Oslo , Norway.
Sophie Mouillet-RichardUMR-S1124, INSERM, Université Paris Descartes, Sorbonne Paris Cité , Paris , France.
Arild EspenesDepartment of Basic Sciences and Aquatic Medicine, Faculty of Veterinary Medicine and Biosciences, Norwegian University of Life Sciences , Oslo , Norway.
Wilfred GoldmannThe Roslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh , Edinburgh , UK.
Jörg TatzeltBiochemistry of Neurodegenerative Diseases, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum , Bochum , Germany.
Michael A TranulisDepartment of Basic Sciences and Aquatic Medicine, Faculty of Veterinary Medicine and Biosciences, Norwegian University of Life Sciences , Oslo , Norway.
Norwegian University of Life Sciences · NOUniversity of Edinburgh · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/A/00001651Biotechnology and Biological Sciences Research Council BBS/E/D/20251967Biotechnology and Biological Sciences Research Council BBS/E/D/20251968Biotechnology and Biological Sciences Research Council BBS/E/D/20251969
6 · The paper itself

Abstract

Despite intensive studies since the 1990s, the physiological role of the cellular prion protein (PrP(C)) remains elusive. Here, we present a novel concept suggesting that PrP(C) contributes to immunological quiescence in addition to cell protection. PrP(C) is highly expressed in diverse organs that by multiple means are particularly protected from inflammation, such as the brain, eye, placenta, pregnant uterus, and testes, while at the same time it is expressed in most cells of the lymphoreticular system. In this paradigm, PrP(C) serves two principal roles: to modulate the inflammatory potential of immune cells and to protect vulnerable parenchymal cells against noxious insults generated through inflammation. Here, we review studies of PrP(C) physiology in view of this concept.

Indexed as

Alzheimercell signalingcytoprotectionimmune modulationimmune privilegeinflammationneurodegenerationprion protein

Identifiers

PMID26388873
PMCPMC4557099
OpenAlexW2121088512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.